Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Jose Romero

Concepts (173)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Cerebral Small Vessel Diseases
6
2024
7
3.910
Why?
Stroke
13
2023
492
2.880
Why?
Dementia
3
2024
141
2.250
Why?
Cerebral Hemorrhage
9
2023
104
1.220
Why?
Magnetic Resonance Imaging
14
2023
1537
1.210
Why?
Brain
8
2023
1328
0.910
Why?
Alzheimer Disease
2
2022
324
0.800
Why?
Cerebral Amyloid Angiopathy
4
2023
4
0.740
Why?
Hypertension
2
2020
533
0.520
Why?
Thrombolytic Therapy
3
2020
110
0.510
Why?
Longitudinal Studies
6
2022
688
0.480
Why?
Humans
38
2024
49974
0.460
Why?
Brain Ischemia
3
2020
161
0.440
Why?
Risk Factors
13
2023
3613
0.420
Why?
Tick-Borne Diseases
1
2012
6
0.420
Why?
Aged
16
2023
9310
0.390
Why?
Parechovirus
1
2011
2
0.380
Why?
Anti-Bacterial Agents
3
2017
744
0.380
Why?
Viral Vaccines
1
2011
12
0.380
Why?
Picornaviridae Infections
1
2011
18
0.370
Why?
Respiratory Syncytial Virus Infections
1
2010
36
0.370
Why?
Antibodies, Viral
1
2011
88
0.370
Why?
Respiratory Sounds
1
2010
48
0.360
Why?
RNA, Viral
1
2011
125
0.360
Why?
Respiratory Tract Infections
1
2010
75
0.350
Why?
Infant, Premature, Diseases
1
2010
94
0.350
Why?
Male
21
2023
25241
0.340
Why?
Female
22
2023
26472
0.340
Why?
Genome-Wide Association Study
3
2023
166
0.320
Why?
Pneumonia, Viral
2
2020
168
0.290
Why?
Coronavirus Infections
2
2020
177
0.280
Why?
Tissue Plasminogen Activator
3
2021
109
0.260
Why?
Cohort Studies
7
2021
1422
0.260
Why?
Motor Cortex
2
2002
13
0.260
Why?
Chromosomes, Human, Pair 10
1
2023
3
0.230
Why?
Incidence
6
2021
1003
0.230
Why?
Basal Ganglia
1
2023
26
0.220
Why?
Middle Aged
11
2022
12069
0.220
Why?
Infarction
1
2022
14
0.220
Why?
Fibrinolytic Agents
2
2021
124
0.210
Why?
Plaque, Atherosclerotic
1
2022
38
0.210
Why?
Carotid Stenosis
1
2022
63
0.200
Why?
Electromagnetic Fields
1
2002
16
0.200
Why?
Mental Health
1
2024
219
0.200
Why?
Early Medical Intervention
1
2020
8
0.180
Why?
Sinus Thrombosis, Intracranial
1
2020
17
0.180
Why?
Ischemic Attack, Transient
1
2021
56
0.180
Why?
Image Interpretation, Computer-Assisted
1
2021
106
0.180
Why?
Atherosclerosis
1
2023
214
0.180
Why?
Asymptomatic Diseases
1
2020
36
0.180
Why?
Iron
1
2021
122
0.180
Why?
Cardiovascular Diseases
2
2023
440
0.180
Why?
Neurology
1
2020
41
0.180
Why?
Data Interpretation, Statistical
1
2020
158
0.170
Why?
Radiography, Interventional
1
2020
60
0.170
Why?
Societies, Medical
1
2020
175
0.170
Why?
tau Proteins
1
2019
26
0.170
Why?
Venous Thrombosis
1
2020
90
0.170
Why?
Aged, 80 and over
7
2021
3129
0.170
Why?
Needs Assessment
1
2020
133
0.170
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
1
2020
138
0.170
Why?
Recombinant Fusion Proteins
1
2010
181
0.170
Why?
Risk Assessment
2
2020
1259
0.160
Why?
Health Services Needs and Demand
1
2020
158
0.160
Why?
Angiogenesis Inhibitors
1
2010
187
0.160
Why?
Papillomavirus Vaccines
1
2019
61
0.160
Why?
Pneumococcal Vaccines
1
2017
8
0.150
Why?
Pharmacies
1
2019
61
0.150
Why?
Pneumococcal Infections
1
2017
8
0.150
Why?
Streptococcus pneumoniae
1
2017
22
0.150
Why?
Community Pharmacy Services
1
2019
68
0.150
Why?
Endovascular Procedures
1
2020
173
0.150
Why?
Arthritis, Infectious
1
2017
44
0.150
Why?
Prevalence
1
2020
944
0.140
Why?
Stroke, Lacunar
1
2016
1
0.140
Why?
Papillomavirus Infections
1
2019
155
0.140
Why?
Emotions
1
2017
165
0.140
Why?
Osteomyelitis
1
2017
126
0.140
Why?
Antibodies, Monoclonal
1
2010
459
0.130
Why?
Retrospective Studies
6
2022
6108
0.130
Why?
Ovarian Neoplasms
1
2010
447
0.130
Why?
United States
5
2020
4860
0.120
Why?
Stenotrophomonas maltophilia
1
2014
6
0.120
Why?
Gram-Negative Bacterial Infections
1
2014
39
0.120
Why?
Leptin
1
2015
140
0.120
Why?
Meningitis, Meningococcal
1
2013
3
0.120
Why?
Meningococcal Infections
1
2013
4
0.120
Why?
Child, Preschool
4
2020
3871
0.110
Why?
RNA-Directed DNA Polymerase
1
2002
6
0.110
Why?
Oligodeoxyribonucleotides
1
2002
29
0.110
Why?
Bacteremia
1
2013
90
0.110
Why?
Infant
4
2017
3567
0.100
Why?
Evoked Potentials, Motor
2
2002
7
0.100
Why?
Neutrophils
1
2013
145
0.100
Why?
Amyloid beta-Peptides
2
2023
69
0.100
Why?
DNA, Complementary
1
2002
135
0.100
Why?
Tularemia
1
2012
21
0.100
Why?
Ehrlichiosis
1
2012
15
0.100
Why?
Brain Infarction
2
2022
12
0.100
Why?
Lyme Disease
1
2012
32
0.100
Why?
Antineoplastic Agents
1
2010
1171
0.100
Why?
Pandemics
3
2020
559
0.100
Why?
Upper Extremity Deep Vein Thrombosis
1
2011
3
0.100
Why?
Embolism, Paradoxical
1
2011
3
0.100
Why?
Intracranial Embolism
1
2011
27
0.090
Why?
Foramen Ovale, Patent
1
2011
27
0.090
Why?
Administration, Intravenous
2
2020
69
0.090
Why?
Mycobacterium tuberculosis
1
2002
285
0.090
Why?
Adult
6
2021
13236
0.080
Why?
Massachusetts
2
2019
25
0.080
Why?
Prospective Studies
3
2020
2364
0.080
Why?
Anticoagulants
2
2021
250
0.080
Why?
Infant, Premature
1
2010
318
0.070
Why?
Severity of Illness Index
1
2010
945
0.070
Why?
Infant, Newborn
2
2014
2772
0.070
Why?
Cross-Sectional Studies
2
2023
1557
0.070
Why?
Arkansas
1
2012
1977
0.070
Why?
Treatment Outcome
3
2020
5141
0.070
Why?
Child
4
2020
6847
0.060
Why?
Case-Control Studies
2
2020
1131
0.060
Why?
Young Adult
3
2020
3958
0.060
Why?
Electromyography
2
2002
131
0.060
Why?
Methyltransferases
1
2023
27
0.060
Why?
Constriction, Pathologic
1
2022
94
0.050
Why?
Carotid Arteries
1
2022
85
0.050
Why?
Adolescent
3
2020
6356
0.050
Why?
Antihypertensive Agents
1
2023
117
0.050
Why?
Nerve Net
1
2002
69
0.050
Why?
Endothelial Cells
1
2023
269
0.050
Why?
Genomics
1
2023
286
0.050
Why?
Polymorphism, Single Nucleotide
1
2023
485
0.050
Why?
Atrophy
1
2020
38
0.050
Why?
Neuroimaging
1
2021
84
0.050
Why?
Polysomnography
1
2020
71
0.050
Why?
Genetic Predisposition to Disease
1
2023
510
0.050
Why?
Boston
1
2020
12
0.050
Why?
Endocrine System Diseases
1
2010
10
0.040
Why?
Receptors, Vascular Endothelial Growth Factor
1
2010
22
0.040
Why?
Fluid Therapy
1
2020
76
0.040
Why?
Critical Pathways
1
2020
39
0.040
Why?
Vascular Diseases
1
2020
75
0.040
Why?
Triage
1
2020
62
0.040
Why?
Thrombectomy
1
2020
67
0.040
Why?
Brain Mapping
1
2020
235
0.040
Why?
Skin Diseases
1
2010
112
0.040
Why?
Gastrointestinal Diseases
1
2010
126
0.040
Why?
Antibodies, Monoclonal, Humanized
1
2010
225
0.040
Why?
Pharmacists
1
2019
144
0.040
Why?
Drug Resistance, Bacterial
1
2017
71
0.040
Why?
Vaccination
1
2019
266
0.040
Why?
Sensitivity and Specificity
1
2019
861
0.040
Why?
Pilot Projects
1
2019
699
0.040
Why?
Microbial Sensitivity Tests
1
2017
269
0.030
Why?
Waist-Hip Ratio
1
2015
6
0.030
Why?
Radioimmunoassay
1
2015
44
0.030
Why?
Reproducibility of Results
1
2019
1193
0.030
Why?
Clavulanic Acids
1
2014
8
0.030
Why?
Ticarcillin
1
2014
8
0.030
Why?
Proportional Hazards Models
1
2015
402
0.030
Why?
Neisseria meningitidis
1
2013
5
0.030
Why?
Time Factors
1
2020
2903
0.030
Why?
Leukocyte Count
1
2013
70
0.030
Why?
Intensive Care Units
1
2014
222
0.030
Why?
Predictive Value of Tests
1
2015
903
0.030
Why?
DNA Primers
1
2002
207
0.030
Why?
Transcription, Genetic
1
2002
369
0.020
Why?
Oligonucleotide Array Sequence Analysis
1
2002
411
0.020
Why?
Gene Expression Regulation, Bacterial
1
2002
191
0.020
Why?
RNA, Messenger
1
2002
1105
0.020
Why?
Prognosis
1
2013
1942
0.020
Why?
Electric Stimulation
1
2002
118
0.010
Why?
Transcranial Magnetic Stimulation
1
2002
70
0.010
Why?
Cerebral Cortex
1
2002
200
0.010
Why?
Romero's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description